Total Intl Bond ETF Vanguard (BNDX)
$58.12 0.02 (0.03%)
16:41 EDT BNDX Stock Quote Delayed 30 Minutes
Previous Close $58.12
Market Cap 12.02B
PE Ratio -
Volume (Avg. Vol.) 1.98M
Day's Range 58.10 - 58.17
52-Week Range 53.89 - 58.97
Dividend & Yield 1.23 (2.11%)
BNDX Stock Predictions, Articles, and Total Intl Bond ETF Vanguard News
- From InvestorPlace
- From the Web
Do you want to perfectly diversify your portfolio with just two exchange-traded funds? If so, start by picking from some of these best funds.
The other prominent theme has been investors' ongoing affinity for inexpensive ETFs. While not all of the best ETFs are extremely cheap, there are plenty of strong funds out there with low expense ratios and those fees are falling. Additionally, basically every brokerage firm of note eliminated commissions on ETFs this year, so the asset class is becoming even more cost-effective to embrace.
These Vanguard funds check a lot of boxes for income-starved, risk-averse investors looking for action in a volatile market.
Vanguard funds are spread across multiple asset classes, including domestic and international equities, various fixed income segments, real estate and some factor-based strategies. So when it comes to Vanguard funds, there is usually something for nearly every type of investor.
There are plenty of opportunities in the New Year with currency ETFs. Here are five ETFs investors should consider for significant gains.
U.S. stocks have had a good run, but now it's time for international stocks to shine. Get exposure to these with these 7 ETFs to buy.
These ex-U.S. offerings include funds tracking international stocks and international bonds. These Vanguard ETFs can help juice your yield.
Using Vanguard ETFs makes adding international stocks easy. Here are three low-cost ways to get more global exposure with your portfolio.
Vanguard ETFs are among the industry's least expensive, but finding the best Vanguard ETFs is about more than just picking the cheapest.
One way to prepare for the coming rate hike is to look to international ETFs like DXJ, BNDX and DBEF for some diversity.
There are plenty of choices for bond etfs to buy that have a high yield, you just have to know where to look.
Aimmune Therapeutics rallies on Nestle acquiring, Akcea cheers Ionis acquiring 24% remaining stake, ADiTx Therapeutics and Lipocine among major losers
Gainers: Aimmune Therapeutics (NASDAQ:AIMT) +172%, Akcea Therapeutics (NASDAQ:AKCA) +60%, Pro-Dex (NASDAQ:PDEX) +16%, Kindred Biosciences (NASDAQ:KIN) +14%, Neuronetics (NASDAQ:STIM) +11%.Losers: ADiTx Therapeutics (NASDAQ:ADTX) -11%, Lipocine (NASDAQ:LPCN) -11%, Orchard Therapeutics (NASDAQ:ORTX) -11%, CNS Pharmaceuticals (NASDAQ:CNSP) -9%, Anchiano Therapeutics (NASDAQ:ANCN) -8%.
Gainers: Equillium (NASDAQ:EQ) +220%.electroCore (NASDAQ:ECOR) +175%.WiMi Hologram Cloud (NASDAQ:WIMI) +73%.NovaBay Pharmaceuticals (NYSEMKT:NBY) +40%.Benefytt Technologies (NASDAQ:BFYT) +37%.OncoSec Medical (NASDAQ:ONCS) +37%.Vaxart (NASDAQ:VXRT) +37%.Lizhi (NASDAQ:LIZI) +35%.BiondVax Pharmaceuticals (NASDAQ:BVXV) +31%.Net Element (NASDAQ:NETE) +29%.Losers: Celsion (NASDAQ:CLSN) -63%.Gritstone Oncology (NASDAQ:GRTS) -50%.NextCure (NASDAQ:NXTC) -44%.Anchiano Therapeutics (NASDAQ:ANCN) -32%.Hermitage Offshore Services (NYSE:PSV) -30%.Senmiao Technology (NASDAQ:AIHS) -20%.Arcimoto (NASDAQ:FUV) -19%.Tarena International (NASDAQ:TEDU) -19%.iMedia Brands (NASDAQ:IMBI) -16%.BlueCity Holdings (NASDAQ:BLCT) -16%.